GBA Presents: RADIO SAVANT-!

stonedinvestor said:
THIS IS SO WEIRD. No sooner did I type that then a commercial comes on for GNRC Power Cell.. guess what it's solar!!!!! And it's ugly.. they must be feeling the pinch of the diesel price....
More...


Have you seen the commercial? /

Looking at GNRC as a short<-- Diesel too expensive to run their generators.../ move into Solar seems desperate.
 
vanzandt said:
I suppose if we get a bounce today we're gonna have to hear about your 2PM call earlier.
Even if it happens right out of the gate lol.
The vix is at 30 Stoney, things go up, they go down. Anybody can make hairbrain calls everyday and be right half the time.
More...


Do you think are going to bounce right out of the gate?
 
The vix is at 30 Stoney, things go up, they go down. Anybody can make hairbrain calls everyday and be right half the time.

That may be true but I've been right four in a row. Put some respect on that!
 
Wow yesterday tied up in the hold of the ship. With little research to work with... and not even at the wheel I come though with a huge gainer in SEED & nailed a huge SHORt in NLS in the SAME DAY!

Beat That Robin Hod!
 
Nautilus price target lowered to $5 from $14 at Lake Street 09:06 NLS Lake Street analyst Mark Smith lowered the firm's price target on Nautilus to $5 from $14 and keeps a Buy rating on the shares after the company faced weak demand for cardio products that drove most of the year-over-year decline in revenue seen in Q4. The company gave FY23 guidance well below his expectations as demand in both the retail and direct channels continues to slow, noted Smith, who thinks that there is opportunity in the at-home fitness model, but also thinks the environment remains challenging in the near-term.
 
Maxim sees GeoVax Labs undervalued, citing its MVA vaccine in monkeypox 08:35 GOVX Maxim analyst Jason McCarthy keeps his Buy rating and $6.00 price target on GeoVax Labs, stating that despite the 100% rally in the stock last week, the company remains "undervalued" as it trades below cash. McCarthy adds that the MVA-based vaccine technology that GeoVax uses has already demonstrated protection against monkeypox as part of its HIV vaccines previously, stating that when monkeypox surfaced, health authorities went straight to MVA given its "proven efficacy, safety, and durability".

GeoVax Labs receives notice of allowance for cancer vaccine patent in China 09:05 GOVX GeoVax Labs announced…


GeoVax Labs, Inc. (GOVX)
NasdaqCM - NasdaqCM
2.3200+0.9300 (+66.91%)
At close: May 23 04:00PM EDT
2.7500 +0.4300 (+18.5345%)<--------:caution:
Pre-Market: 9:25AM EDT

This was $1 Fri folks--- may be too hot.
 
You must log in or register to reply here.
Back
Top